Ben Solomon, Lung Cancer Medical Oncologist at Peter MacCallum Cancer Centre, shared a post by International Association for the Study of Lung Cancer on X and added:

“A timely discussion with Narjust Florez amazing host of International Association for the Study of Lung Cancer Lung Cancer Considered podcast about the ALINA trial given the recent U.S. FDA approval of adjuvant alectinib for resected ALK+ NSCLC! Thanks Narjust Florez!”

Quoting International Association for the Study of Lung Cancer’s post:

“In the wake of the U.S. FDA approval of alectinib for resected NSCLC, host Narjust Florez and guest Ben Solomon discuss this development and take a deeper look at the ALINA trial, which included patients with resected stage II/III NSCLC with an ALK fusion.”

View additional information.
Source: Ben Solomon/X and International Association for the Study of Lung Cancer/X

About OncoDaily 

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.